86 related articles for article (PubMed ID: 15158691)
1. Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts.
Evig CB; Kelley EE; Weydert CJ; Chu Y; Buettner GR; Burns CP
Nitric Oxide; 2004 May; 10(3):119-29. PubMed ID: 15158691
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy influences inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) activity on 3D breast cancer cell line.
Oktem G; Bilir A; Selvi N; Yurtseven ME; Vatansever S; Ates U; Uysal A; Omay SB
Oncol Res; 2006; 16(4):195-203. PubMed ID: 17120617
[TBL] [Abstract][Full Text] [Related]
3. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of doxorubicin and docetaxel on nitric oxide production and inducible nitric oxide synthase expression in MCF-7 human breast cancer cells.
Oktem G; Karabulut B; Selvi N; Sezgin C; Sanli UA; Uslu R; Yurtseven ME; Omay SB
Oncol Res; 2004; 14(7-8):381-6. PubMed ID: 15301429
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of nitric oxide protection against tert-butyl hydroperoxide-induced cytotoxicity in iNOS-transduced human erythroleukemia cells.
Yalowich JC; Gorbunov NV; Kozlov AV; Allan W; Kagan VE
Biochemistry; 1999 Aug; 38(33):10691-8. PubMed ID: 10451363
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
Dusre L; Mimnaugh EG; Myers CE; Sinha BK
Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
[TBL] [Abstract][Full Text] [Related]
7. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells.
Binder C; Schulz M; Hiddemann W; Oellerich M
Lab Invest; 1999 Dec; 79(12):1703-12. PubMed ID: 10616218
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS.
Luss H; Li RK; Shapiro RA; Tzeng E; McGowan FX; Yoneyama T; Hatakeyama K; Geller DA; Mickle DA; Simmons RL; Billiar TR
J Mol Cell Cardiol; 1997 Apr; 29(4):1153-65. PubMed ID: 9160867
[TBL] [Abstract][Full Text] [Related]
9. Glutathione regulates nitric oxide synthase in cultured hepatocytes.
Harbrecht BG; Di Silvio M; Chough V; Kim YM; Simmons RL; Billiar TR
Ann Surg; 1997 Jan; 225(1):76-87. PubMed ID: 8998123
[TBL] [Abstract][Full Text] [Related]
10. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral-mediated gene transfer of nitric oxide synthase isoforms and vascular cell proliferation.
Cooney R; Hynes SO; Duffy AM; Sharif F; O'Brien T
J Vasc Res; 2006; 43(5):462-72. PubMed ID: 16921253
[TBL] [Abstract][Full Text] [Related]
12. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy.
Tikoo K; Sane MS; Gupta C
Toxicol Appl Pharmacol; 2011 Mar; 251(3):191-200. PubMed ID: 21194538
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide enhancement of melphalan-induced cytotoxicity.
Cook JA; Krishna MC; Pacelli R; DeGraff W; Liebmann J; Mitchell JB; Russo A; Wink DA
Br J Cancer; 1997; 76(3):325-34. PubMed ID: 9252199
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells.
Muir CP; Adams MA; Graham CH
Breast Cancer Res Treat; 2006 Mar; 96(2):169-76. PubMed ID: 16331349
[TBL] [Abstract][Full Text] [Related]
15. Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition?
Olukman M; Can C; Erol A; Oktem G; Oral O; Cinar MG
Anadolu Kardiyol Derg; 2009 Aug; 9(4):260-6. PubMed ID: 19666426
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 induction by endogenous nitric oxide: influence of intracellular glutathione.
André M; Felley-Bosco E
FEBS Lett; 2003 Jul; 546(2-3):223-7. PubMed ID: 12832044
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli.
Zamora R; Vodovotz Y; Alarcon L; Betten B; Loughran PA; Aulak KS; Stuehr DJ; Gibson KF; Billiar TR
Arch Biochem Biophys; 2001 Jun; 390(2):287-94. PubMed ID: 11396931
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids.
Wartenberg M; Schallenberg M; Hescheler J; Sauer H
Int J Cancer; 2003 Apr; 104(3):274-82. PubMed ID: 12569550
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IkappaB.
Chang K; Lee SJ; Cheong I; Billiar TR; Chung HT; Han JA; Kwon YG; Ha KS; Kim YM
Exp Mol Med; 2004 Aug; 36(4):311-24. PubMed ID: 15365250
[TBL] [Abstract][Full Text] [Related]
20. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production.
Hohmeier HE; Thigpen A; Tran VV; Davis R; Newgard CB
J Clin Invest; 1998 May; 101(9):1811-20. PubMed ID: 9576743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
